These findings suggest that this mouse model can be used as a pre-clinical model to test the efficacy of anti PD-1/PD-L1 therapy (e.g. pembrolizumab) in UPS. The gene discussed is CD274; the disease is undifferentiated pleomorphic sarcoma.